Print this Page


Venture Capital

More than 1,460 entities are in California’s medical pipeline from discovery to marketed products. This represents 21 percent of the total biomedical pipeline in the U.S. (total 6,904).

The top six disease areas of drug development for the California life science industry are cancer, neurology, infectious disease, endocrine and metabolic disorders, autoimmune diseases and disorders, cardiovascular disease. More than 70 percent of the drug discovery and development efforts are in these six areas and correlates to the prevalence of diseases and disorders affecting patients in the U.S.

Permanent link to this article: